MedTrace Logo

Non-invasive, Real-time Anesthetic Drug-monitoring System

NCT02776020 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2016-05-18

No results posted yet for this study

Summary

The aim of this study is to determine efficacy of the "CorrecDose" device to continuously and non-invasively follow the changes in propofol concentrations in the participants' blood.

Conditions

  • Anesthesia

Interventions

DEVICE

CorrecDose Infrared Monitor

The monitor is attached to patient's wrist and ear in order to measure changes in propofol concentrations in blood

Sponsors & Collaborators

  • Rambam Health Care Campus

    lead OTHER

Principal Investigators

  • Philippe Abecassis, MD · Rambam

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2016-12-31
Completion
2017-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02776020 on ClinicalTrials.gov